CSL Behring is a global biotherapeutics leader focused on using the latest technologies. Based in Melbourne, Australia, CSL Behring recently announced plans for an estimated 1.8 million-square-foot expansion of its operations in Kankakee, Illinois.

CSL is celebrating its 65th anniversary in the area, where it currently employs more than 1,400 people. The company will begin its expansion with CSL South (its current campus will be known as CSL North), a $240 million, 300,000-square-foot, seven-story tower building. The company recently purchased a 74-acre former edible oil plant adjacent to its existing 65-acre site.

“The future is even brighter. We are really setting ourselves up for the future. We plan on bringing more and more of our products here to Kankakee,” said Tricia Stewart, Sr. Vice President & General Manager of the Kankakee site.